EUVIMEDObjevte EUVIMED
CrossrefInformační karta

Comparison of dose escalation strategies for head and neck cancer patients using a radiobiological model of reoxygenation

Mariana Guerrero, Ema C. Smith, David J. Carlson

Medical Physics · 2026-11 · 53 (11)

DOI: 10.1002/mp.70705 ↗
AbstraktBibliografické údaje

Abstrakt

Abstract Purpose Advanced imaging techniques for head‐and‐neck (HN) cancers can now quantify inter‐ and intra‐tumor variation in tumor hypoxia. Dose‐escalation based on pre‐treatment hypoxia in clinical trials typically boost initial hypoxic areas. However, longitudinal studies demonstrated that the location of hypoxic cells changes throughout treatment. Our goal is to further a model of reoxygenation and quantify the potential loss of biological effectiveness due to changes in hypoxia during treatment in dose‐escalation studies based on initial hypoxia only and compare this strategy to one based on patient selection according to imaging at weeks 0 and 2 of treatment and boosting of the whole treatment volume. Methods A published reoxygenation model based on LQ survival formulas with reoxygenation parameter is extended to allow for dose‐escalation with dose per fraction for initial hypoxic cells. The new model allows for hypoxic cells to miss the escalated dose depending on parameter “ m ” ( m = 0 no hypoxic cells missed). Using published radiobiological parameters, we calculate the EQD2 when hypoxia is present for 70Gy delivered in 35 fractions with using two different dose escalation strategies. Results Based on assumed parameters, the increase in EQD2 associated with escalated dose per fraction up to 2.6Gy cannot sufficiently compensate for the reduction in biological effect due to hypoxia if . As increases to 0.2 and above the EQD2 becomes comparable to the non‐hypoxic values. Based on previous results, the dose‐escalation of the whole tumor after 20Gy based on hypoxia imaging at 2 weeks yields comparable or higher EQD2 values for more modest escalated doses to the whole tumor. Conclusions The proposed reoxygenation model allows evaluation and comparison of strategies for dose‐escalation to compensate for hypoxia during treatment and quantification of the limitations of dose‐escalation based on the initial distribution of hypoxia in a dynamic system of tumor oxygenation.

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.

Zobrazit tarify →